Noliprel Forte (Indapamide, Perindopril Arginine)

Indapamide and Perindopril Arginine, the active ingredients in Noliprel Forte, are an ACE inhibitor and thiazide‑like diuretic combination presented as an oral tablet for oral use. It treats hypertension in adult patients.

GNH USA supplies Noliprel Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noliprel Forte is an antihypertensive medication that acts on the renin‑angiotensin system and renal sodium handling. - Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Secondary hypertension: assists in controlling blood pressure when underlying causes are present. - Isolated systolic hypertension: improves pulse pressure in older adults.

Noliprel Forte may cause a range of adverse reactions.

Common Side Effects: - Dizziness or light‑headedness, especially after the first dose. - Headache. - Cough, often dry. - Fatigue or weakness. - Electrolyte disturbances such as low potassium. - Increased urination.

Serious or Rare Side Effects: - Angioedema or swelling of the face, lips, tongue, or throat. - Severe hypotension, particularly in volume‑depleted patients. - Acute kidney injury or worsening renal function. - Hyperkalemia. - Liver enzyme elevation. - Blood dyscrasias such as neutropenia.

Before initiating Noliprel Forte, consider the following precautions. - Renal impairment: monitor kidney function and adjust therapy as needed. - Hepatic disease: use with caution; liver enzymes should be checked periodically. - Electrolyte imbalance: assess serum potassium and sodium levels before and during treatment. - Pregnancy: classified as Category D; avoid use unless benefits outweigh risks. - Elderly patients: start at lower doses and monitor for orthostatic hypotension. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Noliprel Forte can interact with several medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Lithium: increased lithium levels and potential toxicity. - NSAIDs (e.g., ibuprofen, naproxen): may blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Other ACE inhibitors or ARBs: additive blood‑pressure lowering and renal effects. - Thiazide diuretics: may enhance electrolyte disturbances. - Antidiabetic agents: possible enhancement of hypoglycemic effect. - Antimicrobials such as trimethoprim‑sulfamethoxazole: may increase risk of hyperkalemia.